Nucleic Acid Drug Design Lab

AboutAbout the lab

Creating artificial nucleic acids to produce nucleic acid therapeutics.

The Nucleic Acid Therapeutics Design Lab studies the development of nucleic acid therapeutics that use artificially made nucleic acids.
The lab works on synthesizing artificial nucleic acids to be introduced into nucleic acid therapeutics such as antisense nucleic acids and aptamers, and on developing screening methods to efficiently select promising sequences.
Because nucleic acid therapeutics can target almost any molecule in the body, including DNA, RNA, and proteins, they are expected to lead to the development of highly effective drugs for intractable diseases that are difficult to treat with existing methods.
The lab's website presents it as the "Artificial Nucleic Acid Screening Project" of the National Institutes of Biomedical Innovation, Health and Nutrition, and students from the Graduate School of Pharmaceutical Sciences at Osaka University join as cooperative graduate students.

MembersFaculty

The members of the Nucleic Acid Therapeutics Design Lab are project leaders, sub-project leaders, specially appointed researchers, technical assistants, administrative assistants, visiting researchers, cooperative graduate students, and trainees.

• Project LeaderYuya Kasahara